RIGEL PHARMACEUTICALS, INC. Interest Expense Nonoperating
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Interest Expense Nonoperating of $779.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-04
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $779.00K, a 58.43% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $1.43M, a 22.67% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2025-06-30 was $1.87M.
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for the quarter ending 2025-03-31 was $1.85M.
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for fiscal 2025 was $7.32M, a 7.55% decline from fiscal 2024.
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for fiscal 2024 was $7.92M, a 15.22% increase from fiscal 2023.
- RIGEL PHARMACEUTICALS, INC. interest expense nonoperating for fiscal 2023 was $6.87M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|
| 2026-06-30 | $779.00K 10-Q · filed 2026-08-04 | $2.21M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $1.43M 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | $7.32M 10-K · filed 2026-03-03 | ||
| 2025-06-30 | $1.87M 10-Q · filed 2026-08-04 | $3.73M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $1.85M 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | $7.92M 10-K · filed 2026-03-03 | ||
| 2023-12-31 | $6.87M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |